What is LXR-623 used for?

LXR-623 is currently a research compound and does not have an approved use for any medical condition.

Is LXR-623 an approved drug?

No, LXR-623 is in Phase 1 of development and is not an approved medication.

What are the side effects of LXR-623?

There is no information available regarding the side effects of LXR-623 in the provided data.

Is LXR-623 safe for humans?

Because LXR-623 is in the early research phase, its safety profile for humans has not been established.

Can I take LXR-623 with other medications?

The provided data does not list any known drug interactions for LXR-623.

Is LXR-623 used in clinical trials?

Yes, LXR-623 is listed as being in Phase 1 of development.

Lxr-623 | CAS 875787-07-8 | KYWWJENKIMRJBI

Loading compound...

Small molecule research compound

LXR-623 is a small molecule compound currently in early-stage research (Phase 1). It is being studied for its biological activities, but it is not currently an approved medication for any specific medical condition.

How it worksThe specific biological mechanism of LXR-623 is not detailed in the available data, though it has been tested against 44 different biological targets.

Class

Small moleculeSmall molecule research compound

How to take

This compound is currently in the research phase and is not approved for consumer use or specific medical indications according to the provided data.

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Frequently asked questions (6)